CYTOSOLIC CALCIUM AND INSULIN RESISTANCE IN ELDERLY PATIENTS WITH ESSENTIAL-HYPERTENSION

被引：81

作者：

BYYNY, RL ^{[1
]}

LOVERDE, M ^{[1
]}

LLOYD, S ^{[1
]}

MITCHELL, W ^{[1
]}

DRAZNIN, B ^{[1
]}

机构：

[1] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80262

来源：

AMERICAN JOURNAL OF HYPERTENSION | 1992年 / 5卷 / 07期

关键词：

HYPERTENSION; INSULIN RESISTANCE; CYTOSOLIC CALCIUM;

D O I：

10.1093/ajh/5.7.459

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

We evaluated insulin sensitivity in normotensive (blood pressure, BP, < 135/85 mm Hg) and hypertensive (BP > 160/90 mm Hg) elderly subjects over 65 years old who were stratified as normal weight (body mass index, BMI, < 27) and obese (BMI > 27). Obese hypertensive individuals demonstrated marked hyperinsulinemia (P < .01) and significantly reduced (P < .05) submaximally stimulated adipocyte 2-deoxyglucose (2-DOG) uptake (abdominal wall fat biopsy). Normal weight hypertensive subjects also demonstrated higher levels of insulinemia and lower insulin-stimulated 2-DOG uptake than nonobese controls. Adipocyte [Ca2+]i levels were elevated in all elderly subjects compared to young individuals (P < .01). Basal and maximally stimulated 2-DOG uptake were similar in all groups. One month of therapy with a calcium channel blocker, 10 mg nitrendipine twice daily, reduced blood pressure in the hypertensive subjects, reduced plasma insulin to control values during an oral glucose tolerance test in obese hypertensive individuals (P < .01), and restored adipocyte 2-DOG uptake at submaximally effective insulin concentration to control values in normal weight and obese hypertensive subjects. In summary, older hypertensive, and particularly older obese hypertensive, patients manifest significant insulin resistance accompanied by elevated levels of [Ca2+]i in their adipocytes.

引用

页码：459 / 464

页数：6

共 17 条

[1]

Ferrannini E., Buzzigoli G., Bonadonna R., Et al., Insulin resistance in essential hypertension, N Engl J Med, 317, pp. 350-357, (1987)

[2]

Resnick L.M., Calcium metabolism in hypertension and allied metabolic disorders, Diabetes Care, 14, pp. 505-520, (1991)

[3]

Sowers J.R., Zemel M., Clinical implications of hypertension in the diabetic patient, Am J Hypertens, 3, pp. 415-424, (1990)

[4]

Draznin B., Sussman K.E., Eckel R.H., Et al., Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia, J Clin Invest, 82, pp. 1848-1852, (1988)

[5]

Segal S., Lloyd S., Sherman N., Et al., Postprandial changes in cytosolic free calcium and glucose uptake in adipocytes in obesity and non-insulin dependent-diabetes mellitus, Hormone Res, 34, pp. 39-44, (1990)

[6]

Sheu W.-H., Swislocki A., Chen Y.-D., Et al., Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension, Am J Hypertens, 4, pp. 199-205, (1991)

[7]

Kelly K.L., Deeney J., Corkey B.E., Cytosolic calcium in adipocytes: Distinct mechanisms of regulation and effects on insulin action, J Biol Chem, 264, pp. 12754-12757, (1989)

[8]

Blaustein M.P., Sodium ions, calcium ions, blood pressure regulation, and hypertension: A reassessment of a hypothesis, Am J Physiol, 232, pp. C165-C173, (1977)

[9]

Okada K., Caramelo C., Tsai P., Et al., Effect of inhibition of Na+/K+-ATPase on vascular action of vasopressin, J Clin Invest, 86, pp. 1241-1248, (1990)

[10]

Lindner A., Kenny M., Meacham A.J., Effects of a circulating factor in patients with essential hypertension on intracellular free calcium in normal platelets, N Engl J Med, 316, pp. 509-513, (1987)

← 1 2 →